Although HER2 kinase mutations have been detected in some cancers including lung adenocarcinomas [11], mutation of HER2 does not appear to be required to confer transforming potential in mammary epithelial cells, as the amplified HER2 found in overexpressing tumors is generally wild-type. The gene discussed is ERBB2; the disease is cancer.